In focus · trending topic

CSE: VRT

24 stories · following the connections

Veritas Intends to Complete the 100% Takeover of Cannevert Therapeutics in Q1

By Nasdaq OMXFeb 20, 2018, 8:10 AM UTC

Veritas’ Research Arm Cannevert Signs Clinical Research Agreement for Human Studies to Assess its Lead Cannabis Strain for Pain

By Nasdaq OMXJan 10, 2018, 10:01 PM UTC

Veritas Pharma Provides Comment on U.S. Attorney General Jeff Sessions Memo

By Nasdaq OMXJan 9, 2018, 8:05 AM UTC

Veritas Pharma Provides Year End Update on Company’s Activities to Shareholders

By Nasdaq OMXJan 4, 2018, 11:14 PM UTC

Dr. Brian O’Connor Joins Veritas Pharma Advisory Board

By Nasdaq OMXJan 2, 2018, 8:05 AM UTC

Veritas and Cannevert Complete Prestudy Visit of the Puerto Rico Clinical Trial Facility

By Nasdaq OMXDec 29, 2017, 8:05 AM UTC

Veritas Pharma Subsidiary Receives Health Canada Dealer Licence

By Nasdaq OMXDec 28, 2017, 8:05 AM UTC

Veritas Hires Medical Director to Advise Physicians & Regulators on the Application of Cannevert’s Experimental Results with Cannabis to Clinical Practice & Public Policy

By Nasdaq OMXDec 8, 2017, 8:05 AM UTC